LD-2 disclosure · 1st Quarter - Termination (No Activity)
ALGAD BIOPROCESS
Coverage · No income or expenses were reported on this filing.
Client
- Name
- ALGAD BIOPROCESS
- Description
- Development of bioprocessing technology
- Government entity
- true
- Location
- Brazil
Registrant
- Description
- Research and development of disruptive biotechnology for fuel ethanol production.
- Location
- Washington, D.C. 20006, District of Columbia, United States of America